worldinoutRegisterLogin | Set Homepage | Save desktop | Mobile | Qr code
Member
HANGZHOU PANYU CHEMICAL CO.,LIMITED
Pharmaceutical Intermediates;Antibiotics Drugs;Antiviral Drugs
 
Your current location:Home » Sell » 4-Phenyl-1-Butanol 3360-41-6 Pharmaceutical Intermediates Pranlukast Salmeter...

4-Phenyl-1-Butanol 3360-41-6 Pharmaceutical Intermediates Pranlukast Salmeterol Intermediate

Click image to view full size image
Title: 4-Phenyl-1-Butanol 3360-41-6 Pharmaceutical Intermediates Pranlukast Salmeterol Intermediate 
Brand: -
Model: -
Unit price: Negotiable
MOQ: -0 -
Quantity: Negotiable
Delivery date: Since the payment date Days delivery

Contact: Miss. Lily Hou (Ms.)    
Mobile:
Telephone:

  Inquiry
Details

4-Phenyl-1-Butanol 3360-41-6 Pharmaceutical Intermediates Pranlukast Salmeterol Intermediate

 

 

              Application:Pranlukast &Salmeterol intermediates;Pharmaceuticals Intermediates

               Purity :98%

 

Molecular Formula C10H14O Molecular Weight 150.22
Melting point   Density 0.984
Boiling point 140 ºC (14 mmHg) Refractive index 1.52-1.522
Water solubility   Safety Description S23;S24/25

 

               

Company profile              

Our company, as one of the most experienced exporter in China,specializes in API

and medicine intermediates. We export large quantity to USA,Europe and many other

countries all of the world, deal to high quality and reasonable price.

 

Patent Disclaimer:
1.Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
2.Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
3.R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.


4-Phenyl-1-Butanol 3360-41-6 Pharmaceutical Intermediates Pranlukast Salmeterol Intermediate
Inquiry
Sell
  • No Category
New Login
Company QR code
Anytime Anywhere Mobile